Proteomic discovery of CSF biomarkers for Alzheimer's disease [3]

Annals of Neurology

Volumn 61, Issue 5, 2007, Pages 497-

  Zhang, Jing ^a   Montine, Thomas J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; HUMAN; LETTER; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS;

EID: 34249943681     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21109     Document Type: Letter

References (3)

1. Finehout EJ, Franck Z, Choe LH, et al. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol 2007;61: 120-129.
2. Abdi F, Quinn JF, Jankovic J, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 2006;9:293-348.
3. Montine TJ, Woltjer RL, Pan C, et al. Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease. NeuroRx 2006;3:336-343.